Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HRX-0233 |
Trade Name | |
Synonyms | HRX0233|HRX 0233 |
Drug Descriptions |
HRX-0233 is a MAP2K4 inhibitor, which potentially synergizes with MAPK or KRAS inhibitors to decrease tumor growth (PMID: 38377196). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HRX-0233 | HRX-0233 | 0 | 0 |
HRX-0233 + RMC-6236 | HRX-0233 RMC-6236 | 0 | 0 |
HRX-0233 + SCH772984 | HRX-0233 SCH772984 | 0 | 0 |
HRX-0233 + Sotorasib | HRX-0233 Sotorasib | 0 | 0 |
HRX-0233 + Trametinib | HRX-0233 Trametinib | 0 | 0 |